Início › Câncer de Estômago › Texas

Ensaios clínicos de Câncer de Estômago em Texas

60 estudos para Câncer de Estômago estão buscando participantes em locais em Texas.

Cidades em Texas

Texto oficial do estudo (Inglês)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

The Don and Sybil Harrington Cancer Center, Amarillo
UT MD Anderson Cancer Center, Houston
Audie L Murphy VA Hospital, San Antonio

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06760819

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NEXT Oncology, Austin
UT Southwestern, Dallas

RecrutandoFase 1

Idades 19 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06586957

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Texas Oncology - Amarillo Cancer Center, Amarillo
Texas Oncology-Austin Central, Austin
Texas Oncology, Beaumont
e mais 4

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07221149

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Research Site, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06219941

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Baylor Scott & White Health, Dallas
MD Anderson Cancer Center, Houston

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07700979

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NEXT Houston, Galveston
NEXT Oncology - PARENT, San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07360314

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

NEXT Dallas, Irving

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07578571

IKS014 in Advanced Solid Tumors That Express HER2

START Dallas - Fort Worth, Fort Worth

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05872295

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

US Oncology Investigational Products Center (IPC), Irving

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07392892

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Baylor, Scott and White Research Institute, Dallas

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Houston

RecrutandoFase 2

Idades de 18 a 130 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

MD Anderson, Houston
NEXT Dallas, Irving
NEXT Oncology San Antonio, San Antonio
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Texas Oncology - DFW (Sammons CC), Dallas
MD Anderson Cancer Center, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Texas Oncology - DFW (Sammons CC), Dallas
Baylor College of Medicine, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07213791

A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
NEXT Oncology, San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07705334

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Texas Oncology (Balcones) - SCRI, Austin
MD Anderson Cancer Center, Houston
START South Texas Accelerated Research Therapeutics, San Antonio

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05267626

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Start - Dfw, Fort Worth
Oncology Consultants, Houston
START - San Antonio, San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

NEXT Oncology - Austin, Austin
Mary Crowley Cancer Research, Dallas
MD Anderson Cancer Center - University of Texas, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06253871

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Dallas
Research Site, Dallas
Research Site, Houston
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07431281

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

Mary Crowley Cancer Research, Dallas

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06750185

Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors

UT MD Anderson Cancer Center, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06364410

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

The University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), LLC, San Antonio

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07070232

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NEXT Austin, Austin
NEXT San Antonio, San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07227168

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, Houston
Research Site, San Antonio

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07115043

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

MD Anderson Cancer Center, Houston
NEXT Dallas, Irving

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT07066657

A Study of MGC026 in Participants With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
University of Texas Health Science Center at Houston, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The University of Texas, MD Anderson Cancer Center, Houston
UT Health Mays Cancer Center, San Antonio

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT05592626

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

UT Southwestern Medical Center, Dallas
Texas Oncology, P.A. - Tyler, Tyler

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 10 de ago. de 2026 · NCT06731478

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, San Antonio

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT07749586

IDOV-Immune for Advanced Solid Tumors

MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics, San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT06910657

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Texas Oncology, Dallas
Oncology Consultants, Houston
Texas Oncology, Tyler

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT03526835

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

The University of Texas Health Science Center at Tyler, Tyler

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jul. de 2026 · NCT04198766

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #129, Houston

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jul. de 2026 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
UT Southwestern Medical Center - Redbird, Dallas
Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
e mais 8

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
NEXT Dallas, Irving
South Texas Accelerated Research Therapeutics, LLC, San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de jul. de 2026 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Texas Oncology - Central South, Austin
START San Antonio, LLC., San Antonio

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 15 de jul. de 2026 · NCT06657144

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Texas Oncology - DFW, Dallas
MD Anderson Cancer Center, Houston

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 10 de jul. de 2026 · NCT06695845

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Oncology Consultants, PA, Houston
Oncology Consultants, PA., Houston
The University of Texas M.D. Anderson Cancer Center, Houston
e mais 5

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT04389632

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.